352 related articles for article (PubMed ID: 25393577)
1. Epidemiology and treatment of lacrimal gland tumors: a population-based cohort analysis.
Mallen-St Clair J; Arshi A; Tajudeen B; Abemayor E; St John M
JAMA Otolaryngol Head Neck Surg; 2014 Dec; 140(12):1110-6. PubMed ID: 25393577
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, Prognostic Factors, and Treatment of Malignant Submandibular Gland Tumors: A Population-Based Cohort Analysis.
Lee RJ; Tan AP; Tong EL; Satyadev N; Christensen RE
JAMA Otolaryngol Head Neck Surg; 2015 Oct; 141(10):905-12. PubMed ID: 26378411
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.
Lee RJ; Arshi A; Schwartz HC; Christensen RE
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):470-7. PubMed ID: 25811167
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With Survival in Patients With Synovial Cell Sarcoma of the Head and Neck: An Analysis of 167 Cases Using the SEER (Surveillance, Epidemiology, and End Results) Database.
Mallen-St Clair J; Arshi A; Abemayor E; St John M
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):576-83. PubMed ID: 27100936
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
6. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Squamous Cell Carcinoma of the Lip in the United States: A Population-Based Cohort Analysis.
Han AY; Kuan EC; Mallen-St Clair J; Alonso JE; Arshi A; St John MA
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1216-1223. PubMed ID: 27832256
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma.
Ford JR; Rubin ML; Frank SJ; Ning J; Debnam JM; Bell D; El-Naggar A; Ferrarotto R; Esmaeli B
Br J Ophthalmol; 2021 Jun; 105(6):768-774. PubMed ID: 32680839
[TBL] [Abstract][Full Text] [Related]
9. Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review.
Holliday MA; Tavaluc R; Zhuang T; Wang H; Davidson B
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):362-6. PubMed ID: 23599071
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological trends in malignant lacrimal gland tumors.
Andreoli MT; Aakalu V; Setabutr P
Otolaryngol Head Neck Surg; 2015 Feb; 152(2):279-83. PubMed ID: 25385802
[TBL] [Abstract][Full Text] [Related]
11. Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population-based analysis.
He LF; Zhang JD; Zhu TF; Zhao PC; Mou P; Tang SY
Cancer Med; 2024 Feb; 13(3):e6831. PubMed ID: 38230983
[TBL] [Abstract][Full Text] [Related]
12. Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of the Minor Salivary Gland.
Baddour HM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):67-73. PubMed ID: 26632951
[TBL] [Abstract][Full Text] [Related]
13. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.
Chen TY; Keeney MG; Chintakuntlawar AV; Knutson DL; Kloft-Nelson S; Greipp PT; Garrity JA; Salomao DR; Garcia JJ
Eye (Lond); 2017 May; 31(5):720-725. PubMed ID: 28085142
[TBL] [Abstract][Full Text] [Related]
14. The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis.
Wushou A; Jiang YZ; Liu YR; Shao ZM
Oncotarget; 2015 Dec; 6(39):41875-83. PubMed ID: 26496033
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
Lee IJ; Lee RJ; Fahim DK
World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
[TBL] [Abstract][Full Text] [Related]
16. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.
Yang J; Zhou C; Wang Y; Fan X; Jia R
BMC Ophthalmol; 2019 Jun; 19(1):125. PubMed ID: 31176360
[TBL] [Abstract][Full Text] [Related]
17. Head & neck acinar cell carcinoma: a population-based study using the seer registry.
Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A
BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.
Lee KC; Chuang SK; Philipone EM; Peters SM
Head Neck Pathol; 2019 Sep; 13(3):378-385. PubMed ID: 30357539
[TBL] [Abstract][Full Text] [Related]
19. Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment outcomes.
Arshi A; Tajudeen BA; St John M
Oral Oncol; 2015 Dec; 51(12):1088-94. PubMed ID: 26442813
[TBL] [Abstract][Full Text] [Related]
20. American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma.
Ahmad SM; Esmaeli B; Williams M; Nguyen J; Fay A; Woog J; Selvadurai D; Rootman J; Weis E; Selva D; McNab A; DeAngelis D; Calle A; Lopez A
Ophthalmology; 2009 Jun; 116(6):1210-5. PubMed ID: 19395039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
